InvestorsHub Logo
Followers 1
Posts 39
Boards Moderated 0
Alias Born 12/13/2016

Re: Cruzer98 post# 85735

Tuesday, 12/27/2016 12:11:26 PM

Tuesday, December 27, 2016 12:11:26 PM

Post# of 462062
Yes, $3B was an arbitrary, best guess scenario of what big pharma might value Anavex at today, given current status of things, risk reward ratios and so on. If 2-73 becomes new AlZ SOC, then $3B becomes $30B or moread and the big pharma Finance team looks like geniuses with a 10 fold ROI (and we all retire rich). However, if it doesn't, then big pharma only loses a few hundred million $$, no big deal for someone that big. Hence my $3B valuation as things stand today. That could change tomorrow and could certainly change during P2/P3 trial, question is what's the economic risk someone is willing to put in today ... Whats the value of that call option... My best guess for that is a $3B MC ... cheers
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News